These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6099867)

  • 21. Clinical experience with lower doses of cefotaxime in hospitalized patients with serious infections.
    Shah A; Madhavan T; Drelichman V; Price J
    J Chemother; 1989 Jul; 1(4 Suppl):650-1. PubMed ID: 16312575
    [No Abstract]   [Full Text] [Related]  

  • 22. Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report.
    Reddy J
    N Z Med J; 1984 May; 97(755):293-6. PubMed ID: 6328390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical considerations on the use of cefotaxime in infectious complications after resuscitation].
    Mangione S; Giannalia ML
    Minerva Anestesiol; 1983 Nov; 49(11):649-52. PubMed ID: 6322053
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical efficacy of cefotaxime in two different periods.
    Peralta S; Vitale B; Scarsi C; D'Aiello G; Rotondo G; Delle Vedove G; Rini GB
    J Chemother; 1989 Jul; 1(4 Suppl):648-9. PubMed ID: 16312574
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemotherapy of severe bacterial infections in pediatrics].
    Guggenbichler JP
    Wien Klin Wochenschr Suppl; 1983; 142():20-4. PubMed ID: 6316669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetic, bacteriological and clinical studies of cefotaxime in newborn and immature infants].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Takajo N; Araki H; Imai S; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Hashimoto T; Nakajima H; Matsuo H; Imuta F
    Jpn J Antibiot; 1982 Jul; 35(7):1819-45. PubMed ID: 6294363
    [No Abstract]   [Full Text] [Related]  

  • 27. Cefotaxime: clinical and bacteriologic evaluation.
    Saroglou G; Paniara-Volika O; Sima A; Koltsida K; Rokas S; Kontomichalou P
    Clin Ther; 1981; 4(3):201-11. PubMed ID: 6272994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotaxime therapy for serious infections.
    Tanphaichitra D; Wanvarie S; Srimuang S
    J Med Assoc Thai; 1984 Feb; 67(2):108-10. PubMed ID: 6330259
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of cefotaxime in pneumology.
    Grassi C; Colombo ML; Peona V
    Acta Med Port; 1983 Feb; 4(2):87-90. PubMed ID: 6303060
    [No Abstract]   [Full Text] [Related]  

  • 30. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
    Sen RA; Keaney MG; Ganguli LA
    J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical results and pharmacokinetics of cefotaxime in newborn infants].
    Takimoto M; Oka T; Yoshioka H; Sanae N; Maruyama S
    Jpn J Antibiot; 1982 Jul; 35(7):1816-8. PubMed ID: 6294362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM; Veldkamp J; Deleers L
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefotaxime in the treatment of prophylaxis of surgical infections.
    Wittmann DH; Jones RN; Malledant J; Privitera G
    J Chemother; 1997 May; 9 Suppl 2():19-33. PubMed ID: 9248973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of cefotaxime at Kenyatta National Hospital.
    Shah MV; Kanja C
    East Afr Med J; 1983 Mar; 60(3):196-9. PubMed ID: 6311510
    [No Abstract]   [Full Text] [Related]  

  • 35. Carbapenems in paediatrics.
    Blumer JL
    Scand J Infect Dis Suppl; 1995; 96():38-44. PubMed ID: 7652502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of ceftriaxone (author's transl)].
    Lafaix C; Beucler A; Soussy CJ; Dublanchet A
    Pathol Biol (Paris); 1982 Jun; 30(6):349-52. PubMed ID: 6287387
    [No Abstract]   [Full Text] [Related]  

  • 38. Cefotaxime treatment of patients who failed to respond to previous antibiotics.
    Bruch K; Blomer R
    Br J Clin Pract; 1980 Oct; 34(10):276-8. PubMed ID: 6257265
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reevaluation of current antimicrobials. Cefotaxime sodium].
    Motohiro T; Haruta T
    Jpn J Antibiot; 1994 Aug; 47(8):967-74. PubMed ID: 7933540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.